Melo’s experience at the Elysium 2024 neurorehabilitation conference.
This week, the Melo team had the pleasure of attending the 2024 ‘Conundrums in Neurorehabilitation’ conference in London, hosted by Elysium Healthcare. We wanted to take this opportunity to reflect on what was an exciting and insightful experience.
The event started with a dinner the night before the conference, where co-founders James Chapman and James Burch had the opportunity to reconnect with familiar faces, including Prof. Nick Alderman and Paul Mooney, as well as the chance to connect with new people from a range of healthcare institutions. We also got to hear from Prof. Andrew Worthington who was speaking at the event about the book he co-authored with Nick Alderman, in which Melo had a short section in one of the chapters. These initial conversations really set the tone for the collaborative atmosphere that defined the whole event.
On Wednesday morning, we had the chance to display Melo on it’s own stand, including information about the outcomes from the Salford pilot evaluation. There was a buzz of activity as we engaged new and familiar faces with our live demonstrations of Melo. We were overwhelmed with interest, and were thrilled to build new connections from across the NHS, charity, and private sectors.
Across the day, we had the opportunity to learn from a series of talks that broadened our ever-growing understanding of challenging behaviour. One talk of particular interest was given by Paul Mooney, who talked about research comparing different techniques for managing behaviours that challenge. Positive behaviour support was of particular interest, and is something that we have begun to explore in terms of how we could build this into the platform.
Later in the afternoon, Decently co-founders, JB and JC, took to the main stage to present the Melo journey and lessons learned in a presentation titled “Which button do I press? Can digital health really help understand challenging behaviours in ABI patients?”. Presenting to a packed conference auditorium at the British Medical Association was a fantastic opportunity to share more about Melo, from it’s inception to it’s implementation.
They were able to emphasise the way in which Melo was built, from a ground up approach involving over 500 stakeholders in the initial development process. Alongside this, the presentation also spotlighted the impact of the Salford evaluation project, and the exciting new Elysium project involving the digitisation of the OAS-MNR at Elysium’s Moorlands Neurological centre - including a product demo on stage!
Reflecting after the event, then the vast range of conversations and interest at the conference show just how far Melo has come in the last two years, and as we move forward, we continue to learn from the insights and inspiration of all the people we have met over this time. We are more motivated than ever to continue our mission of helping clinicians have a better understanding of complex behaviours in order to provide the right care at the right time for brain injury patients.